The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 2261-2269.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matheu, M. P.
Right arrow Articles by Cahalan, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matheu, M. P.
Right arrow Articles by Cahalan, M. D.

Class IA Phosphoinositide 3-Kinase Modulates Basal Lymphocyte Motility in the Lymph Node1

Melanie P. Matheu*, Jonathan A. Deane{dagger}, Ian Parker*,§, David A. Fruman2,{dagger},{ddagger} and Michael D. Cahalan2,3,*,{ddagger}

* Department of Physiology and Biophysics, {dagger} Department of Molecular Biology and {ddagger} Biochemistry, § Department Neurobiology and Behavior, and Center for Immunology, University of California, Irvine, California 92697

Recruitment of PI3K to the cell membrane is an indispensable step in normal lymphocyte proliferation and activation. In this study we identify PI3K as an important signaling molecule for maintaining basal T and B lymphocyte motility and homing in the intact lymph node. Pharmacological inhibition of PI3K catalytic isoforms exerted broad effects on basal lymphocyte motility, including changes in homing kinetics, localization of B cells within the lymph node, and reduced cell velocities. Lymphocytes deficient in either or both of the class IA PI3K regulatory subunits p85{alpha} and p85beta also exhibited reduced velocities, with the magnitude of reduction depending upon both cell type and isoform specificity. B cells deficient in p85{alpha} exhibited gross morphological abnormalities that were not evident in cells treated with a PI3K inhibitor. Our results show, for the first time, that class IA PI3Ks play an important role in regulating basal lymphocyte motility and that p85{alpha} regulatory subunit expression is required to maintain B cell morphology in a manner independent of PI3K catalytic function. Moreover, we demonstrate distinct roles for catalytic domain function and class IA PI3K regulatory domain activity in lymphocyte motility, homing, and homeostatic localization of mature resting B cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants GM41514 (to M.D.C.), AI50831 (to D.A.F.), and GM-48071 (to I.P.) and by National Institutes of Health Kirchstein Fellowship AI-64128 (to M.P.M.).

2 D.A.F. and M.D.C. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Michael D. Cahalan, Department of Physiology and Biophysics, University of California, Irvine, CA 92697-4561. E-mail address: mcahalan{at}uci.edu

4 Abbreviations used in this paper: PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisposphate; CMTMR, 5-(and-6)-(((4-chloromethyl) benzol) amino)tetramethylrhodamine); DOCK2, dedicator of cytokinesis 2; KO, knockout; SDF-1, stromal cell-derived factor-1; WMN, wortmannin.

5 The online version of this article contains supplemental material.


Related articles in The JI:

IN THIS ISSUE

The JI 2007 179: 2033-2034. [Full Text]  



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
V. Kolsch, P. G. Charest, and R. A. Firtel
The regulation of cell motility and chemotaxis by phospholipid signaling
J. Cell Sci., March 1, 2008; 121(5): 551 - 559.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.